about
Antithrombotic treatment after intracerebral haemorrhageCarotid artery intima-media thickness is closely related to impaired left ventricular function in patients with coronary artery disease: a single-centre, blinded, non-randomized study.Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke.Reliability and validity of the Canadian Neurological Scale in retrospective assessment of initial stroke severity.The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial.Blood pressure differences between patients with lacunar and nonlacunar infarcts.Antithrombotic treatment after stroke due to intracerebral haemorrhage.A consensus on stroke: early supported discharge.Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.Need for symptomatic management in advanced multiple sclerosis.Reasons for low thrombolysis rate in a Norwegian ischemic stroke population.Outcome after mobilization within 24 hours of acute stroke: a randomized controlled trial.Factors related to decision delay in acute stroke.Early mobilization after acute stroke.Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial.Factors related to knowledge of stroke symptoms and risk factors in a norwegian stroke population.Poststroke epilepsy: occurrence and predictors--a long-term prospective controlled study (Akershus Stroke Study).[Before and after implementation of do-not-resuscitate orders in a stroke unit].Joint meeting of the Association of British Neurologists and theNorwegian Neurological Association on the coastalsteamer Hurtigruten, 6-9 May 2001.Very long-term mortality after ischemic stroke: predictors of cardiovascular death.Transdermal scopolamine to reduce salivation and possibly aspiration after stroke.Prehospital delay in acute stroke and TIA.Prehospital path in acute stroke.Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke.Stroke in the puerperium treated with intra-arterial rt-PA.Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial.Middle Cerebral Artery Pulsatility Index is Associated with Cognitive Impairment in Lacunar Stroke.Reperfusion therapy in stroke cases with unknown onset.Determinants of change in quality of life from 1 to 6 months following acute stroke.The assessment of carotid atherosclerosis using a new multipurpose ultrasound probe.Quality of life 6 months after acute stroke: impact of initial treatment in a stroke unit and general medical wards.[How to diagnose acute stroke?].[Should patients with acute stroke routinely receive supplemental oxygen?][PS-RESKVA (Patient Satisfaction, Results and Quality)--patient satisfaction in hospitals]Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trialIncidence and predictors for post-stroke epilepsy. A prospective controlled trial. The Akershus stroke studyOutcome of subacute stroke rehabilitation: a randomized controlled trialSurvival of unselected stroke patients in a stroke unit compared with conventional care[Acute cerebral symptoms in elderly women][Post-stroke epilepsy]
P50
Q24185972-DE5B25AC-F6C7-419E-9C2F-220A153FD8F2Q30428533-D5D6764D-CFA5-4FCC-B268-BFA6B2E1E1EEQ33937420-645E5D29-E298-4F1D-829A-5B67141CBB0FQ35178924-9142414F-B583-4BBB-B7AA-C1779F358682Q35462109-CF64D8E2-0CF3-48E5-8BDD-A6DD8B96BA13Q36023814-0AC47857-3AE8-468B-BA85-AFEA3FC49FDEQ36379755-70158E55-2468-453F-9B7B-E5D7A38FBB68Q37858266-5F55B641-989A-4CE4-B20A-3E967FAA412DQ38638909-1991C1B2-475C-4906-93F5-74DD5A7E699EQ40675144-9A44A4C2-05F7-4E57-AD3A-82F58B0A0B03Q42672339-53C1CDBA-72F1-46CE-A2BD-17297BFB8282Q44115847-4A0734D8-A0CD-4F1E-878C-F810BE7A25B5Q44131433-DE55E063-F28E-434E-81C2-2D2D21F2FB2EQ44824029-E03E90B1-32ED-4958-8B99-6E0845473C01Q44832888-E6CB44A3-0CE7-47B6-8827-509736027CDDQ44959210-94BF7DAC-7896-48DC-B546-0072CABC5E00Q45051247-42BA1742-BF0D-4A64-8F0E-86AF9C592934Q45105260-8EED2DC6-7079-45B7-AC87-512A8616D790Q45771404-57017F82-F111-473D-9E7C-9B0A63826BDDQ45816760-9C708D58-61E5-409F-816F-A20D2451621BQ46405290-F30FF2E1-B734-418B-8539-441682A645FCQ46737806-2A6E0B01-C9CC-4099-A9E1-4670E45E6C75Q47350822-188FC499-BCFF-463B-9F03-A169EE7544FAQ48169960-B7ECA5B9-C18C-4ED1-B402-3881388EC21FQ48202594-F3E8A053-32A0-4431-AEE7-B058070712E5Q48554368-D1F7F499-E8A3-4610-B220-CCE8E188AD5EQ50544825-5786D646-D33F-4E92-A288-A8C4BAED976FQ51806646-59265E74-6704-4767-A721-139176B382D7Q51896935-61F3B951-4836-48E5-8B8D-455F95362A95Q53076419-519C9DAC-B361-446E-B270-C09558F87281Q53198281-CF277B52-F594-433E-A478-E958993493E5Q53487601-22D4E54D-2577-4E2A-B9F7-67DF5EE89840Q74274528-F08B7F9E-EF13-4980-A99A-D67703A616DAQ74307241-5A4B03DF-79C2-4787-96EE-12A16921A2D9Q74324126-959E9047-F058-4285-8BA8-07672531FAF1Q74417191-7867C976-F3FB-4931-98FB-3D6A32DD63B0Q74460447-BEB6A072-33B1-4457-988E-B9365EEDCC24Q77690627-ECEDDA22-C771-4492-ACC2-BE88D358ACB0Q79236676-1D62E77C-35BC-4146-87F8-8DBED7AA7984Q79742716-389FFC86-A9B8-4EF8-B9DC-3F43F7D7F203
P50
description
Noors onderzoeker
@nl
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Ole Morten Rønning
@ast
Ole Morten Rønning
@en
Ole Morten Rønning
@es
Ole Morten Rønning
@nl
Ole Morten Rønning
@sl
type
label
Ole Morten Rønning
@ast
Ole Morten Rønning
@en
Ole Morten Rønning
@es
Ole Morten Rønning
@nl
Ole Morten Rønning
@sl
prefLabel
Ole Morten Rønning
@ast
Ole Morten Rønning
@en
Ole Morten Rønning
@es
Ole Morten Rønning
@nl
Ole Morten Rønning
@sl
P106
P21
P27
P31
P496
0000-0001-5080-5788